You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
“Drugs to avoid” to improve quality use of medicines: how is Australia faring?
|
|---|---|
| Published in |
Journal of Pharmaceutical Policy and Practice, July 2021
|
| DOI | 10.1186/s40545-021-00346-3 |
| Pubmed ID | |
| Authors |
Agnes Vitry, Barbara Mintzes |
X Demographics
The data shown below were collected from the profiles of 42 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 16 | 38% |
| Canada | 3 | 7% |
| Australia | 3 | 7% |
| Colombia | 2 | 5% |
| Mexico | 2 | 5% |
| United States | 1 | 2% |
| United Kingdom | 1 | 2% |
| Unknown | 14 | 33% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 34 | 81% |
| Practitioners (doctors, other healthcare professionals) | 5 | 12% |
| Scientists | 2 | 5% |
| Science communicators (journalists, bloggers, editors) | 1 | 2% |
Mendeley readers
The data shown below were compiled from readership statistics for 12 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 12 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 3 | 25% |
| Other | 2 | 17% |
| Student > Ph. D. Student | 1 | 8% |
| Unspecified | 1 | 8% |
| Student > Master | 1 | 8% |
| Other | 1 | 8% |
| Unknown | 3 | 25% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 3 | 25% |
| Psychology | 3 | 25% |
| Pharmacology, Toxicology and Pharmaceutical Science | 2 | 17% |
| Unspecified | 1 | 8% |
| Unknown | 3 | 25% |
Attention Score in Context
This research output has an Altmetric Attention Score of 26. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 November 2021.
All research outputs
#1,507,436
of 25,732,188 outputs
Outputs from Journal of Pharmaceutical Policy and Practice
#24
of 525 outputs
Outputs of similar age
#36,435
of 448,297 outputs
Outputs of similar age from Journal of Pharmaceutical Policy and Practice
#2
of 26 outputs
Altmetric has tracked 25,732,188 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 525 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.8. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 448,297 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 26 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 92% of its contemporaries.